The largest insider transaction on today's list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.
Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5%...
We retired our "Five Bull Market Barometers" in 2020 to make room for a new weekly post that's focused on the three most important charts for the week ahead.
While I prefer to let stocks prove themselves to me before taking a position, sometimes a situation sets up where the stars are aligning for a low risk bet that makes it worth the effort to get ahead of the crowd.
One of the processes we absolutely love to follow is the Top/Down Analysis approach. In this process, we identify the larger trend, zoom in, and analyze the characteristics that stand out. We look at the asset classes, identify the strongest one, and...
We got a breadth thrust this week as the percentage of S&P 500 stocks making new 20-day highs edged above 55% on Thursday. This might not be the most well-known of the various breadth thrusts, but...
We've experienced a pretty powerful bear market rally on the heels of yesterday's Federal Reserve interest rates announcement. Whether or not it sticks is anybody's guess. But one name in the financials space has stood out for its relative lack...